CORTICE BIOSCIENCES
Cortice Biosciences is a clinical-stage drug development company pioneering novel therapies for the treatment of oncologic and neurologic indications with urgent unmet medical need. Microtubule stabilizing taxoids for treatment of brain cancers and CNS disease Their lead drug candidate, TPI 287, is a novel microtubule stabilizing taxoid with the unique property of being able to readily penetrate the blood-brain barrier. Accordingly, they are developing TPI 287 for treatment of cancers of the b... rain, including glioblastoma and secondary brain metastases. Given the potential of microtubule stabilization as a therapeutic approach for neurodegenerative diseases known as tauopathies, they are also developing TPI 287 for treatment of progressive supranuclear palsy, corticobasal dementia, and Alzheimer's disease.
CORTICE BIOSCIENCES
Industry:
Biotechnology Therapeutics
Founded:
2014-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.corticebiosciences.com
Status:
Active
Contact:
646.747.9090
Technology used in webpage:
GoDaddy DNS GoDaddy GoDaddy Email
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
GainPep
GainPep is an early-stage drug development company.
Official Site Inspections
http://www.corticebiosciences.com
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago